Pulmonary Hypertension Trial, Recruiting (NCT07457762)

Pulmonary Hypertension Trial, Recruiting NCT07457762 Sponsor: University of Sao Paulo General Hospital Condition: Pulmonary Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT07457762 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pulmonary Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be 18 years old or older
You must be a patient treated at the Heart Institute of the University of São Paulo Medical School's pulmonary hypertension center
You must have been diagnosed with pulmonary arterial hypertension (a type of high blood pressure affecting the lungs) confirmed by an invasive test measuring specific pressure levels in your heart and lungs (confirm with trial site for exact values)
You must currently be using a medication called Iloprost

Who may not be able to join:

You may not be able to join if you are unable to complete a 6-minute walk test, which involves walking as far as you can in 6 minutes
You may not be able to join if you have had bleeding in your digestive system (such as your stomach or intestines) within the last 12 weeks

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07457762

Sponsor: University of Sao Paulo General Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Pulmonary Hypertension

More information: https://clinicaltrials.gov/study/NCT07457762

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be 18 years old or older
You must be a patient treated at the Heart Institute of the University of São Paulo Medical School's pulmonary hypertension center
You must have been diagnosed with pulmonary arterial hypertension (a type of high blood pressure affecting the lungs) confirmed by an invasive test measuring specific pressure levels in your heart and lungs (confirm with trial site for exact values)
You must currently be using a medication called Iloprost

Who may not be able to join:

You may not be able to join if you are unable to complete a 6-minute walk test, which involves walking as far as you can in 6 minutes
You may not be able to join if you have had bleeding in your digestive system (such as your stomach or intestines) within the last 12 weeks

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Sao Paulo General Hospital

Registry

ClinicalTrials.gov

Start date

1 May 2025

Est. completion

28 April 2026

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Medication Adherence Measured by the Martín-Bayarre-Grau (MBG) Questionnaire.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov